MAPT and amyotrophic lateral sclerosis: A small molecule USP14 inhibitor IU1 and an inactive USP14 mutant C114A were shown to reduce the level of the amyotrophic lateral sclerosis (ALS) and dementia disease proteins TDP-43 and tau in mammalian cells [22].